The content is available as a PDF (409.0 KB).
letter . 2021 Nov 27:ciab984. doi: 10.1093/cid/ciab984
Post-vaccination SARS-CoV-2 antibody kinetics and protection duration
Chloé Dimeglio
1,2,✉, Fabrice Herin
3,4, Isabelle Da-Silva
1, Marion Porcheron
1, Guillaume Martin-Blondel
2,5, Sabine Chapuy-Regaud
1, Jacques Izopet
1,2
Chloé Dimeglio
1CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France
2INSERM UMR1291 – CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France
Find articles by Chloé Dimeglio
Fabrice Herin
3Occupational Diseases Department, Toulouse University Hospital, 31000 Toulouse, France
4UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier, Centre for Epidemiology and Research in Population Health Unit (CERPOP), 31000 Toulouse, France
Find articles by Fabrice Herin
Isabelle Da-Silva
1CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France
Find articles by Isabelle Da-Silva
Marion Porcheron
1CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France
Find articles by Marion Porcheron
Guillaume Martin-Blondel
2INSERM UMR1291 – CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France
5Infectious and Tropical Diseases Department, Toulouse University Hospital, 31300 Toulouse, France
Find articles by Guillaume Martin-Blondel
Sabine Chapuy-Regaud
1CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France
Find articles by Sabine Chapuy-Regaud
Jacques Izopet
1CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France
2INSERM UMR1291 – CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France
Find articles by Jacques Izopet
1CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 Toulouse, France
2INSERM UMR1291 – CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France
3Occupational Diseases Department, Toulouse University Hospital, 31000 Toulouse, France
4UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier, Centre for Epidemiology and Research in Population Health Unit (CERPOP), 31000 Toulouse, France
5Infectious and Tropical Diseases Department, Toulouse University Hospital, 31300 Toulouse, France
✉
Corresponding author: Chloe Dimeglio, email: dimeglio.c@chu-toulouse.fr
Received 2021 Nov 16.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC8690160 PMID: 34849639